ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 153 filers reported holding ENDOLOGIX INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,311,000 | -32.0% | 894,318 | +2.1% | 0.01% | -38.1% |
| Q1 2017 | $6,344,000 | +26.6% | 876,208 | 0.0% | 0.02% | +10.5% |
| Q4 2016 | $5,012,000 | -55.3% | 876,208 | 0.0% | 0.02% | -54.8% |
| Q3 2016 | $11,216,000 | +122.7% | 876,208 | +120.4% | 0.04% | +110.0% |
| Q2 2016 | $5,037,000 | – | 397,534 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Capital Management, LLC | 4,050,000 | $62,127,000 | 7.14% |
| Essex Woodlands Management, Inc. | 1,257,468 | $24,875,000 | 4.49% |
| First Light Asset Management, LLC | 304,602 | $4,673,000 | 2.20% |
| ArrowMark Colorado Holdings LLC | 3,464,775 | $53,150,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,449,897 | $37,581,000 | 1.25% |
| Iguana Healthcare Management, LLC | 200,000 | $3,068,000 | 0.97% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 82,316 | $1,262,000 | 0.71% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,651,798 | $25,339,000 | 0.64% |
| PERKINS CAPITAL MANAGEMENT INC | 34,200 | $525,000 | 0.46% |
| CADIAN CAPITAL MANAGEMENT, LP | 967,443 | $14,841,000 | 0.44% |